HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by DIDDLE, A W Articles by O'CONNOR, K. A. Search for Related Content PubMed PubMed Citation Articles by DIDDLE, A W Articles by O'CONNOR, K. A.

Oral Contraceptive Medications and Vulvovaginal Candidiasis

From the Depart of Obstetrics and Gynecology, Memorial Research Center and Hospital, University of Tennessee, Knoxville, Tenn.

Abstract

The incidence of monilial vulvovaginitis was compared between 3179 women given oral contraceptive drugs and 5240 not given them. Clinical monQiasis in the treated patients progressively increased as the duration of oral contraceptive medication increased, whereas the controls' rate of infection was fairly constant. Of the 3179 women given oral contraceptive medications, 44 had had clinical vulvovaginal moniliasis before and continued to have the problem while taking the medications; 181 experienced it for the first time. More than 1 in 10 of the husbands of the 225 affected women had balanoposthitis. One in 17 of the 225 had a hereditary background of diabetes mellitus, but their oral glucose tolerance tests were normal. The incidence of candidiasis was not related to the type of oral contraceptive used. A small percentage of women suffered genital moniliasis repeatedly; such infections did not tend to clear up until the oral contraceptive medication was discontinued.